GE Healthcare’s 2012 Cell Imaging Competition - Voting Opens to Celebrate Art, Science and Discovery Thursday, November 22, 2012 Competition features both high-content analysis and high- and super-resolution microscopy cell images for the first time. BioCat and ALPCO Diagnostics Sign Exclusive Distribution Agreement Tuesday, November 20, 2012 Agreement names BioCat as the exclusive distributor for ALPCO products in Germany. Biologics and Stem Cell Research Boost the Cell Culture Market Thursday, November 15, 2012 Cell culture market expected to grow at a CAGR of 9.3% between 2011 and 2018. Life Technologies Acquires Advanced Microscopy Group Thursday, November 08, 2012 Acquisition provides Life Technologies a complete set of imaging products across range of functionality and price points. Miniaturized Mass-Spectrometry-Based Analysis System for Examination of Conditioned Cell Culture Media Monday, November 05, 2012 Researchers present an automated system that allows in-line sampling of microliter amounts of extracellular conditioned cell culture media, preparing them for MALDI MS analysis. Life Technologies Announces Third Quarter 2012 Results Monday, November 05, 2012 Revenue for the third quarter was $911 million, a decrease of 1.9 percent over the $929 million reported for the third quarter of 2011. Excluding the impact of currency, revenue growth for the quarter was 1.4 percent compared to the same period of the prior year. CCS Cell Culture Service Signs Strategic License Agreement with CEVEC Pharmaceuticals Monday, November 05, 2012 Companies announced today the signing of a strategic license agreement. The license will enable CCS to offer its customers transiently transfected CAP-TTM cells for cell based assay and protein production applications. Tecan and TAP Biosystems Announces a Co-Marketing Agreement Thursday, November 01, 2012 Companies to automate RAFT™ 3D cell culturing on the Freedom EVO®. Thermo Fisher Scientific Reports Q3 Revenue and EPS Results Wednesday, October 24, 2012 Revenue increased 5% to a record $3.09 billion for the third quarter with adjusted operating income rising 5% to $576 million.
|
|
|
|
|
|